• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物治疗学:发病机制与新兴疗法概念。骨与软骨的新型靶点。

Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel targets in bone and cartilage.

机构信息

Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.

出版信息

Best Pract Res Clin Rheumatol. 2010 Aug;24(4):489-96. doi: 10.1016/j.berh.2010.03.001.

DOI:10.1016/j.berh.2010.03.001
PMID:20732647
Abstract

The spectrum of arthritis ranges from erosive (e.g., rheumatoid arthritis) to ossifying disease with formation of new bone (e.g., ankylosing spondylitis and osteoarthritis). The molecular basis for these different patterns of arthritis had long been unclear. In the last few years, however, characterisation of catabolic and anabolic molecular pathways in different forms of arthritis led to a better understanding of joint remodelling and revealed novel therapeutic targets. Recent findings show that catabolic and anabolic molecular pathways govern bone and cartilage remodelling in healthy and arthritic joints. The predominance of catabolic molecular pathways (e.g., receptor activator of nuclear factor-kappaB ligand (RANKL)/RANK and cathepsin K) causes erosive disease whereas anabolic signalling (e.g., Wnt and fibroblast growth factor (FGF)18) favours the formation of new bone including bony spurs and subchondral sclerosis. Other pathways may have a dual function in arthritis (e.g., hedgehog) leading to either catabolic or anabolic joint remodelling dependent on other factors. Key mediators within these signalling pathways may serve as novel targets for treating pathological remodelling of bone and cartilage in arthritis. Molecular pathways govern remodelling processes of bone and cartilage in arthritic joints. Future therapies will likely target the pathologic activity of these molecular pathways to specifically block either catabolic or anabolic joint remodelling in arthritis.

摘要

关节炎的范围从侵蚀性(例如类风湿关节炎)到骨形成性疾病(例如强直性脊柱炎和骨关节炎)。这些不同类型关节炎的分子基础长期以来一直不清楚。然而,在过去的几年中,对不同类型关节炎中分解代谢和合成代谢分子途径的特征描述,使人们对关节重塑有了更好的理解,并揭示了新的治疗靶点。最近的发现表明,分解代谢和合成代谢分子途径控制着健康和关节炎关节中的骨和软骨重塑。分解代谢分子途径(例如核因子-κB 受体激活剂配体(RANKL)/RANK 和组织蛋白酶 K)的优势导致侵蚀性疾病,而合成代谢信号(例如 Wnt 和成纤维细胞生长因子(FGF)18)有利于新骨的形成,包括骨赘和软骨下硬化。其他途径在关节炎中可能具有双重功能(例如刺猬),导致依赖于其他因素的分解代谢或合成代谢关节重塑。这些信号通路中的关键介质可作为治疗关节炎中骨和软骨病理性重塑的新靶点。分子途径控制关节炎关节中骨和软骨的重塑过程。未来的治疗方法可能会针对这些分子途径的病理活性,以特异性阻断关节炎中的分解代谢或合成代谢关节重塑。

相似文献

1
Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel targets in bone and cartilage.药物治疗学:发病机制与新兴疗法概念。骨与软骨的新型靶点。
Best Pract Res Clin Rheumatol. 2010 Aug;24(4):489-96. doi: 10.1016/j.berh.2010.03.001.
2
The role of Wnt proteins in arthritis.Wnt蛋白在关节炎中的作用。
Nat Clin Pract Rheumatol. 2008 Sep;4(9):473-80. doi: 10.1038/ncprheum0881.
3
Future therapeutic targets in osteoporosis.骨质疏松症的未来治疗靶点
Curr Opin Rheumatol. 2009 Jul;21(4):380-5. doi: 10.1097/BOR.0b013e32832cbc2a.
4
A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.一种在细胞水平模拟甲状旁腺激素对骨代谢影响的理论模型。
Mol Cell Biomech. 2009 Jun;6(2):101-12.
5
Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis.Wnt 通路和白细胞介素-17:风湿性疾病中关节重塑的新型调节因子。超越 RANK-RANKL-OPG 轴。
Semin Arthritis Rheum. 2010 Apr;39(5):369-83. doi: 10.1016/j.semarthrit.2008.10.008. Epub 2008 Dec 18.
6
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.英夫利昔单抗对类风湿关节炎患者骨和软骨转换标志物的长期影响。
Ann Rheum Dis. 2008 Mar;67(3):353-7. doi: 10.1136/ard.2007.076604. Epub 2007 Jul 20.
7
Bone morphogenetic proteins in destructive and remodeling arthritis.破坏性和重塑性关节炎中的骨形态发生蛋白
Arthritis Res Ther. 2007;9(2):207. doi: 10.1186/ar2135.
8
Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease.在胶原诱导的关节炎中骨形态发生蛋白信号的动态激活支持其在关节稳态和疾病中的作用。
Arthritis Res Ther. 2008;10(5):R115. doi: 10.1186/ar2518. Epub 2008 Sep 24.
9
Erosive arthritis.侵蚀性关节炎
Arthritis Res Ther. 2007;9 Suppl 1(Suppl 1):S2. doi: 10.1186/ar2166.
10
R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway.R-spondin 1通过调节Wnt信号通路来保护小鼠关节炎期间的炎症性骨损伤。
Arthritis Rheum. 2010 Aug;62(8):2303-12. doi: 10.1002/art.27496.

引用本文的文献

1
Cathepsin K Inhibitors as Potential Drugs for the Treatment of Osteoarthritis.组织蛋白酶K抑制剂作为治疗骨关节炎的潜在药物
Int J Mol Sci. 2025 Mar 22;26(7):2896. doi: 10.3390/ijms26072896.
2
Role of the hedgehog signaling pathway in rheumatic diseases: An overview. hedgehog 信号通路在风湿性疾病中的作用:概述。
Front Immunol. 2022 Aug 25;13:940455. doi: 10.3389/fimmu.2022.940455. eCollection 2022.
3
Global transcriptome analysis to identify critical genes involved in the pathology of osteoarthritis.通过全转录组分析鉴定骨关节炎病理过程中的关键基因。
Bone Joint Res. 2018 May 5;7(4):298-307. doi: 10.1302/2046-3758.74.BJR-2017-0245.R1. eCollection 2018 Apr.
4
Gene Expression Analysis before and after Treatment with Adalimumab in Patients with Ankylosing Spondylitis Identifies Molecular Pathways Associated with Response to Therapy.强直性脊柱炎患者使用阿达木单抗治疗前后的基因表达分析确定了与治疗反应相关的分子途径。
Genes (Basel). 2017 Apr 24;8(4):127. doi: 10.3390/genes8040127.
5
Insight on Bone Morphogenetic Protein 7 in Ankylosing Spondylitis and its association with disease activity and radiographic damage.强直性脊柱炎中骨形态发生蛋白7的见解及其与疾病活动和影像学损伤的关联。
Electron Physician. 2016 Jul 25;8(7):2670-8. doi: 10.19082/2670. eCollection 2016 Jul.
6
Genetic polymorphism in extracellular regulators of Wnt signaling pathway.Wnt信号通路细胞外调节因子的基因多态性
Biomed Res Int. 2015;2015:847529. doi: 10.1155/2015/847529. Epub 2015 Apr 5.
7
Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study.胎球蛋白-A与强直性脊柱炎患者的韧带骨赘相关:一项病例对照研究。
Clinics (Sao Paulo). 2014 Dec;69(10):688-93. doi: 10.6061/clinics/2014(10)07.
8
Polymorphism of interleukin-17 and its relation to mineral density of bones in perimenopausal women.白细胞介素-17基因多态性及其与围绝经期女性骨密度的关系。
Eur J Med Res. 2014 Dec 16;19(1):69. doi: 10.1186/s40001-014-0069-1.
9
The future of osteoarthritis therapeutics: emerging biological therapy.骨关节炎治疗的未来:新兴的生物治疗。
Curr Rheumatol Rep. 2013 Dec;15(12):385. doi: 10.1007/s11926-013-0385-4.
10
Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis.Wnt拮抗剂FRZB的变异等位基因是髋关节形状的决定因素,并改变髋关节形状与骨关节炎之间的关系。
Arthritis Rheum. 2012 May;64(5):1457-65. doi: 10.1002/art.34526.